Is This Biotech Stock After Groundbreaking Approval?
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Guidance on practical actions in your 30s to set up a strong retirement, including saving, debt management, and early investment habits.
16,695 articlesA breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
A major hedge fund just sold its entire Abercrombie & Fitch stake. Here’s what that means for investors, how to inter...
A mid-sized fund wrapped up a $9 million exit from a major pawn shop operator after a rally of about 150% over the ye...
Over the last year, ISCV outpaced IJJ, but market cycles can change on a dime. This guide explains why that edge may ...
A celebrity-led passion project climbs to the top on Apple TV, proving that owning your story and diversifying income...
AI-driven crypto projects are grabbing attention as investors seek growth beyond traditional coins. This article brea...
As 2026 kicks off, crypto markets show surprising resilience. Venezuela's evolving policy and remittance dynamics are...
The Humanoid Robotics ETF BOTT surged 114% in the last year, yet its concentrated Korean and Chinese holdings expose ...
As Berkshire Hathaway enters a new chapter, investors wonder if berkshire's just break from Buffett's time-tested pla...
A leading AI scientist cautions that hyperintelligent machines with their own preservation goals could imperil humani...
Pension funds are quietly pouring billions into a Treasury ETF on a quarterly cadence, a trend reshaping fixed-income...
Cognizant’s new analysis shows AI disruption arriving years ahead of forecasts, with 93% of jobs AI-capable and 30% u...